Vaxart Inc (NASDAQ:VXRT) does about 1.99M shares in volume on a normal day but saw 1803370 shares change hands in Friday trading. The company now has a market cap of 219.06M USD. Its current market price is $1.26, marking an increase of 2.44% compared to the previous close of $1.23. The 52 week high reached by this stock is $1.59 whilst the lowest price level in 52 weeks is $0.53.
Vaxart Inc (VXRT) has a 20-day trading average at $1.1925 and the current price is -20.75% off the 52-week high compared with 137.74% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.0952 and its 200-day simple moving average is $0.8242. If we look at the stock’s price movements over the week, volatility stands at 8.00%, which increases to 8.00% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 59.37 to suggest the stock is neutral.
The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 74.8% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 29, 2021 when Jefferies resumed the stock to “Buy” and issued a price target of between $13 and $12. B. Riley Securities downgraded its price target at $13-$9.
Vaxart Inc (VXRT) stock is up 16.67% over the week and -10.00% over the past month. Its price is 119.97% year-to-date and 70.39% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/30/2023, with the company’s earnings per share (EPS) of -$0.12 above consensus estimates by $0.02. VXRT’s earnings per share are forecast to grow by 21.10% this year and 13.30% over next year. Expected sales for next quarter are $50k, which analysts say will come at $14.73 million for the current fiscal year and next year at $23.1 million. In addition, estimates put the company’s current quarterly revenue at an average of $800k.
To reach the target analysts have set, the stock logically needs to grow 74.8 percent from here.
Outstanding shares total 173.86M with insiders holding 0.97% of the shares and institutional holders owning 18.15% of the company’s common stock. The company has a return on investment of -105.98% and return on equity of -97.94%. The beta has a value of 0.43. Price to book ratio is 3.34 and price to sales ratio is 29.68.
